Dr. Perry Thacker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4233 Camelot Crossing
Valdosta, GA 31602Phone+1 229-469-4383Fax+1 229-469-4584
Education & Training
- University of Utah HealthResidency, Dermatology, 2006 - 2009
- University of Tennessee College of Medicine at ChattanoogaInternship, Internal Medicine, 2003 - 2004
- Mercer University School of MedicineClass of 2003
Certifications & Licensure
- GA State Medical License 2009 - 2026
- FL State Medical License 2016 - 2025
- UT State Medical License 2007 - 2010
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 99 citationsFulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in miceSulochana S. Bhandarkar, Marisa Jaconi, Levi Fried, Michael Y. Bonner, Benjamin Lefkove
The Journal of Clinical Investigation. 2009-08-03 - 48 citationsTris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo.Sulochana S. Bhandarkar, Jacqueline Bromberg, Carol O. Carrillo, Ponniah Selvakumar, Rajendra K. Sharma
Clinical Cancer Research. 2008-09-15 - 67 citationsSolenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesisJack L. Arbiser, Tweeny R Kau, Martha Konar, Krishna K. Narra, Ramani Ramchandran
Blood. 2007-01-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: